Record Display for the EPA National Library Catalog

RECORD NUMBER: 12 OF 15

OLS Field Name OLS Field Data
Main Title Some pharmaceutical drugs.
CORP Author IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.
Publisher World Health Organization, International Agency for Research on Cancer,
Year Published 1996
OCLC Number 36261849
ISBN 9283212665; 9789283212669
Subjects Drugs--Physiological effect--Congresses. ; Carcinogens--Congresses. ; Geneesmiddelen. ; Carcinogeniteit. ; Benzodiazepines--toxicity. ; Estrogen Antagonists--toxicity. ; Hypolipidemic Agents--toxicity. ; Neoplasms--chemically induced. ; Antilipemic Agents--toxicity
Internet Access
Description Access URL
http://monographs.iarc.fr/ENG/Monographs/vol66/volume66.pdf
http://www.ncbi.nlm.nih.gov/books/NBK423860/
https://www.ncbi.nlm.nih.gov/books/NBK423860/
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
EJDM  RC268.57.I26 v.66 1996 Env Science Center Library/Ft Meade,MD 01/30/1998
EKBD  IARC/MON-66 Research Triangle Park Library/RTP, NC 03/14/1997
Collation iv, 514 pages : illustrations ; 25 cm.
Notes
"This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans which met in Lyon, 13-20 February 1996." Includes bibliographical references and index.
Contents Notes
Preamble -- General remarks -- The mongraphs: Benzodiazepines and related compunds and phenytoin: Diazepam. Doxefazepam. Estazolam. Oxazepam. Prazepam. Ripazepam. Temazepam. Phenytoin ; Anti-oestrogenic compounds: Droloxifene. Tamoxifen. Toremifene ; Hypolipidaemic drugs: Clofibrate. Gemfibrozil -- Summary of final evaluations -- Glossary -- Appendix 1. Summary tables of genetic and related effects -- Appendix 2. Activity profiles for genetic and related effects.